While one of the most effective ED drugs Levitra does the wonders for thousands of men who have sexual dysfunction problems, pharmacology has also come up with the idea to help women with similar problems.
The market has been saturated with male enhancers for the last few decades. However, the emergence of the first female ED drug Addyi has sparked an interesting conversation, with people wondering whether its popularity will finally open the market to more drugs targeted towards helping women overcome their sexual complications.
Addyi is a drug designed to help women overcome Hypoactive Sexual Desire Disorder (HSDD). It is a chronic illness that creates a long-term lack of interesting in sexual activity. HSDD has caused many problems for women and their relationships, and the fact that the condition is so underdiagnosed hasn’t helped the matters.
A lot of women usually go untreated because doctors have no idea how to approach their situation. The medical arena has been injecting considerable efforts into solving the female sexual dysfunction issue, producing very little in the way of results, at least when compared to Viagra, Cialis, Levitra and other medications on the market used to treat sexual dysfunction in men.
Addyi, the first notable drug for remedying the female sexual drive, was approved by the Food and Drug Administration following considerable lobbying from Special Interest Groups.
Formally known as Flibanserin, Addyi began as an anti-depressant, with the sexual benefits of the drug only emerging after the drug's manufacturers received educational feedback from the women using it.
Addyi was eventually developed and rebranded as a drug that could remedy the female sex drive. Addyi only hit the market in 2015 after women’s rights parties accused the Food and Drug Administration of gender bias.
Addyi is designed to affect the neurotransmitters in the brain. The drug increases the production of dopamine and norepinephrine, neurotransmitters that play active roles in sexual excitement.
The drug also decreases serotonin production. Serotonin is associated with sexual inhibition. By balancing these neurotransmitters, Addyi is able to restore a woman's libido.
There are claims going around that Addyi is essentially the female Viagra. However, this is the furthest thing from the truth. Male enhancers like Viagra affect the physical attributes of the body, relaxing blood vessels and increasing blood flow where it matters.
On the other hand, Addyi only affects the chemicals in the brain. It has no impact on the physical operations of the body, thus, the drug simply makes women feel excited about the prospect of having sex.